Are lactoferrin receptors in Gram-negative bacteria viable vaccine targets?
A number of important Gram-negative pathogens that reside exclusively in the upper respiratory or genitourinary tract of their mammalian host rely on surface receptors that specifically bind host transferrin and lactoferrin as a source of iron for growth. The transferrin receptors have been targeted for vaccine development due to their critical role in acquiring iron during invasive infection and for survival on the mucosal surface. In this study, we focus on the lactoferrin receptors, determining their prevalence in pathogenic bacteria and comparing their prevalence in commensal Neisseria to other surface antigens targeted for vaccines; addressing the issue of a reservoir for vaccine escape and impact of vaccination on the microbiome. Since the selective release of the surface lipoprotein lactoferrin binding protein B by the NalP protease in Neisseria meningitidis argues against its utility as a vaccine target, we evaluated the release of outer membrane vesicles, and transferrin and lactoferrin binding in N. meningitidis and Moraxella catarrhalis. The results indicate that the presence of NalP reduces the binding of transferrin and lactoferrin by cells and native outer membrane vesicles, suggesting that NalP may impact all lipoprotein targets, thus this should not exclude lactoferrin binding protein B as a target.
KeywordsLactoferrin-binding protein Transferrin binding protein Vaccine Antimicrobial peptides
This work was supported by funding from the Canadian Institutes of Health Research (Grant MOP138273), and the National Sciences and Engineering Council (RGPIN-2016-04555) for ABS.
This study was supported by the Canadian Institutes of Health Research (Grant Number MOP138273) and the National Sciences and Engineering Council of Canada (Discovery Grant 298351-2010).
Compliance with ethical standards
Conflict of interest
ABS is a stakeholder in Engineered Antigens Inc.
- Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA, Formsma K, Gerdes S, Glass EM, Kubal M, Meyer F, Olsen GJ, Olson R, Osterman AL, Overbeek RA, McNeil LK, Paarmann D, Paczian T, Parrello B, Pusch GD, Reich C, Stevens R, Vassieva O, Vonstein V, Wilke A, Zagnitko O (2008) The RAST server: rapid annotations using subsystems technology. BMC Genom 9:75. https://doi.org/10.1186/1471-2164-9-75 CrossRefGoogle Scholar
- Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, Lesin VM, Nikolenko SI, Pham S, Prjibelski AD, Pyshkin AV, Sirotkin AV, Vyahhi N, Tesler G, Alekseyev MA, Pevzner PA (2012) SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 19(5):455–477. https://doi.org/10.1089/cmb.2012.0021 CrossRefPubMedPubMedCentralGoogle Scholar
- Brooks CL, Arutyunova E, Lemieux MJ (2014) The structure of lactoferrin-binding protein B from Neisseria meningitidis suggests roles in iron acquisition and neutralization of host defences. Acta Crystallograph Sect F 70(Pt 10):1312–1317. https://doi.org/10.1107/S2053230X14019372 CrossRefGoogle Scholar
- Calmettes C, Ing C, Buckwalter CM, El Bakkouri M, Chieh-Lin Lai C, Pogoutse A, Gray-Owen SD, Pomes R, Moraes TF (2015) The molecular mechanism of Zinc acquisition by the neisserial outer-membrane transporter ZnuD. Nat Commun 6:7996. https://doi.org/10.1038/ncomms8996 CrossRefPubMedPubMedCentralGoogle Scholar
- Danve B, Lissolo L, Guinet F, Boutry E, Speck D, Cadoz M, Nassif X, Quentin-Millet MJ (1998) Safety and immunogenicity of a Neisseria meningitidis group B transferrin binding protein vaccine in adults. In: Nassif X, Quentin-Millet M-J, Taha M-K (eds) 11th International Pathogenic Neisseria Conference, Nice, 1998. Eleventh International Pathogenic Neisseria ConferenceGoogle Scholar
- Frandoloso R, Martinez-Martinez S, Calmettes C, Fegan J, Costa E, Curran D, Yu R, Gutierrez-Martin CB, Rodriguez-Ferri EF, Moraes TF, Schryvers AB (2015) Nonbinding site-directed mutants of transferrin binding protein B enhances their immunogenicity and protective capabilities. Infect Immun 83(3):1030–1038CrossRefPubMedPubMedCentralGoogle Scholar
- Kellner J, Scheifele D, Vanderkooi O, MacDonald J, Church D (2008) Effects of routine infant vaccination with the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization with streptococcus pneumoniae in children in Calgary, Canada. Pediatr Infect Dis J 27:526–532CrossRefPubMedGoogle Scholar
- Maiden MC, Ibarz-Pavon AB, Urwin R, Gray SJ, Andrews NJ, Clarke SC, Walker AM, Evans MR, Kroll JS, Neal KR, Ala’aldeen DA, Crook DW, Cann K, Harrison S, Cunningham R, Baxter D, Kaczmarski E, Maclennan J, Cameron JC, Stuart JM (2008) Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J Infect Dis 197(5):737–743. https://doi.org/10.1086/527401 CrossRefPubMedGoogle Scholar
- Noinaj N, Easley NC, Oke M, Mizuno N, Gumbart J, Boura E, Steere AN, Zak O, Aisen P, Tajkhorshid E, Evans RW, Gorringe AR, Mason AB, Steven AC, Buchanan SK (2012) Structural basis for iron piracy by pathogenic Neisseria. Nature 483:53–58. https://doi.org/10.1038/nature10823 CrossRefPubMedPubMedCentralGoogle Scholar
- Rokbi B, Mignon M, Maitre-Wilmotte G, Lissolo L, Danve B, Caugant DA, Quentin-Millet M-J (1997) Evaluation of recombinant transferrin binding protein B variants from Neisseria meningitidis for their ability of induce cross reactive and bactericidal antibodies against a genetically diverse collection of serogroup B strains. Infect Immun 65(1):55–63PubMedPubMedCentralGoogle Scholar
- Schaar V, Nordstrom T, Morgelin M, Riesbeck K (2011) Moraxella catarrhalis outer membrane vesicles carry beta-lactamase and promote survival of Streptococcus pneumoniae and Haemophilus influenzae by inactivating amoxicillin. Antimicrob Agents Chemother 55(8):3845–3853. https://doi.org/10.1128/AAC.01772-10 CrossRefPubMedPubMedCentralGoogle Scholar
- Schryvers AB (1990) A method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same. France Patent 052878700528787/EP B1Google Scholar
- Schryvers AB, Moraes TF, Gray-Owen SD (2014) Immunogenic compositions and vaccines derived from bacterial surface receptor proteins. PCT/CA2014/051146Google Scholar
- Stearns JC, Davidson CJ, McKeon S, Whelan FJ, Fontes ME, Schryvers AB, Bowdish DM, Kellner JD, Surette MG (2015) Culture and molecular-based profiles show shifts in bacterial communities of the upper respiratory tract that occur with age. ISME J 9(5):1246–1259. https://doi.org/10.1038/ismej.2014.250 CrossRefPubMedPubMedCentralGoogle Scholar
- Tettelin H, Saunders NJ, Heidelberg J, Jeffries AC, Nelson KE, Eisen JA, Ketchum KA, Hood DW, Peden JF, Dodson RJ, Nelson WC, Gwinn ML, DeBoy R, Peterson JD, Hickey EK, Haft DH, Salzberg SL, White O, Fleischmann RD, Dougherty BA, Mason T, Ciecko A, Parksey DS, Blair E (2000) Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science 287(5459):1809–1815CrossRefPubMedGoogle Scholar